下载掌阅APP，畅读海量书库
立即打开
[1] BRAY F，FERLAY J，SOERJOMATARAM I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin，2018，68（6）：394-424.
[2] Cancer Genome Atlas Research Network.Comprehensive genomic characterization of squamous cell lung cancers[J].Nature，2012，489（7417）：519-525.
[3] DEVARAKONDA S，MORGENSZTERN D，GOVINDAN R.Genomic alterations in lung adenocarcinoma[J].Lancet Oncol，2015，16（7）：e342-351.
[4] CAMPBELL JD，ALEXANDROV A，KIM J，et al.Distinct patterns of somatic genome alterations in lung adenocarcinoma and squamous cell carcinomas[J].Nat Genet，2016，48（6）：607-616.
[5] 石远凯.中国肿瘤内科进展（2016年）[M].北京：中国协和医科大学出版社，2016：48-53.
[6] VANDERWALDE A，SPETZLER D，XIAO N，et al.Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11，348 patients[J].Cancer Med，2018，7（3）：746-756.
[7] RUSCH V，CHAFT J，JOHNSON B，et al.MA04.09 Neoadjuvant Atezolizumab in resectable non-small cell lung cancer（NSCLC）：Updated results from a multicenter study（LCMC3）[J].J ThoracOncol，2018，13（10S）：S369.